Structural basis of heteromeric Smad protein assembly in TGF-β signaling

Molecular Cell

Volumn 15, Issue 5, 2004, Pages 813-823

  Chacko, Benoy M ^a   Qin, Bin Y ^a   Tiwari, Ashutosh ^a   Shi, Genbin ^b   Lam, Suvana ^a   Hayward, Lawrence J ^a   De Caestecker, Mark ^b   Lin, Kai ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SUBUNIT; SMAD PROTEIN; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CALORIMETRY; CONTROLLED STUDY; CRYSTAL STRUCTURE; ELECTRICITY; ENTHALPY; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALS; COS CELLS; CRYSTALLOGRAPHY, X-RAY; DNA-BINDING PROTEINS; HEAT; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PHOSPHORYLATION; POLYMERS; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TEMPERATURE; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 4444250157     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.07.016     Document Type: Article

References (44)

1. Abdollah S., Macias-Silva M., Tsukazaki T., Hayashi H., Attisano L., Wrana J.L. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272:1997;27678-27685
2. Attisano L., Wrana J.L. Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12:2000;235-243
3. Blobe G.C., Schiemann W.P., Lodish H.F. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342:2000;1350-1358
4. Boulanger M.J., Bankovich A.J., Kortemme T., Baker D., Garcia K.C. Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130. Mol. Cell. 12:2003;577-589
5. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921
6. Chacko B.M., Qin B., Correia J.J., Lam S.S., de Caestecker M.P., Lin K. The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization. Nat. Struct. Biol. 8:2001;248-253
7. Correia J.J., Chacko B.M., Lam S.S., Lin K. Sedimentation studies reveal a direct role of phosphorylation in Smad3:Smad4 homo- and hetero-trimerization. Biochemistry. 40:2001;1475-1482
8. de Caestecker M.P., Piek E., Roberts A.B. Role of transforming growth factor-beta signaling in Cancer. J. Natl. Cancer Inst. 92:2000;1388-1402
9. Dennler S., Huet S., Gauthier J.M. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene. 18:1999;1643-1648
10. Derynck R., Zhang Y., Feng X.H. Smads. transcriptional activators of TGF-beta responses Cell. 95:1998;737-740
11. Feng X.H., Lin X., Derynck R. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J. 19:2000;5178-5193
12. Goumans M.J., Valdimarsdottir G., Itoh S., Lebrin F., Larsson J., Mummery C., Karlsson S., ten Dijke P. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol. Cell. 12:2003;817-828
13. Hahn S.A., Schutte M., Hoque A.T., Moskaluk C.A., da Costa L.T., Rozenblum E., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 271:1996;350-353
14. Heldin C.H., Miyazono K., ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471
15. Inman G.J., Hill C.S. Stoichiometry of active smad-transcription factor complexes on DNA. J. Biol. Chem. 277:2002;51008-51016
16. Jayaraman L., Massague J. Distinct oligomeric states of SMAD proteins in the transforming growth factor-beta pathway. J. Biol. Chem. 275:2000;40710-40717
17. Jones S., Thornton J.M. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA. 93:1996;13-20
18. Jones A.T., Zou J.-Y., Cowan S.W., Kjeldgaard M. Improved methods for building proteins models in electron-density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119
19. Kawabata M., Inoue H., Hanyu A., Imamura T., Miyazono K. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17:1998;4056-4065
20. Labbe E., Silvestri C., Hoodless P.A., Wrana J.L., Attisano L. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell. 2:1998;109-120
21. Lagna G., Hata A., Hemmati-Brivanlou A., Massague J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature. 383:1996;832-836
22. Massague J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19:2000;1745-1754
23. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., Tamaki K., Hanai J., Heldin C.H., Miyazono K., et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16:1997;5353-5362
24. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation model. Methods Enzymol. 276:1997;307-326
25. Park Y.C., Burkitt V., Villa A.R., Tong L., Wu H. Structural basis for self-association and receptor recognition of human TRAF2. Nature. 398:1999;533-538
26. Qin B., Lam S.S.W., Lin K. Crystal structure of a transcriptionally active smad4 fragment. Structure. 7:1999;1493-1503
27. Qin B.Y., Chacko B.M., Lam S.S., de Caestecker M.P., Correia J.J., Lin K. Structural basis of Smad1 activation by receptor kinase phosphorylation. Mol. Cell. 8:2001;1303-1312
28. Qin B.Y., Lam S., Correia J.J., Lin K. Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control. Genes Dev. 16:2002;1950-1963
29. Qin B.Y., Liu C., Lam S.S., Srinath H., Delston R., Correia J.J., Derynck R., Lin K. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat. Struct. Biol. 10:2003;913-921
30. Qing J., Liu C., Choy L., Wu R.Y., Pagano J.S., Derynck R. Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter. Mol. Cell. Biol. 24:2004;1411-1425
31. Roberts A.B. TGF-beta signaling from receptors to the nucleus. Microbes Infect. 1:1999;1265-1273
32. Shi Y., Hata A., Lo R.S., Massague J., Pavletich N.P. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature. 388:1997;87-93
33. Shi Y., Wang Y.F., Jayaraman L., Yang H., Massague J., Pavletich N.P. Crystal structure of a Smad MH1 domain bound to DNA. insights on DNA binding in TGF-beta signaling Cell. 94:1998;589-594
34. Souchelnytskyi S., Tamaki K., Engstrom U., Wernstedt C., ten Dijke P., Heldin C.H. Phosphorylation of Ser465 and Ser467 in the C terminus of smad2 mediates interaction with smad4 and is required for transforming growth factor-beta signaling. J. Biol. Chem. 272:1997;28107-28115
35. von Gersdorff G., Susztak K., Rezvani F., Bitzer M., Liang D., Bottinger E.P. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J. Biol. Chem. 275:2000;11320-11326
36. Wieser R., Wrana J.L., Massague J. GS domain mutations that constitutively activate TβR-1, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14:1995;2199-2208
37. Wiseman T., Williston S., Brandts J.F., Lin L.N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179:1989;131-137
38. Wrana J.L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-beta receptor. Nature. 370:1994;341-347
39. Wu J.W., Fairman R., Penry J., Shi Y. Formation of a stable heterodimer between Smad2 and Smad4. J. Biol. Chem. 276:2001;20688-20694. a
40. Wu J.W., Hu M., Chai J., Seoane J., Huse M., Li C., Rigotti D.J., Kyin S., Muir T.W., Fairman R., et al. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH. 2(domain and insights on Smad function in TGF-beta signaling. Mol. Cell 8):2001;1277-1289. b
41. Yagi K., Goto D., Hamamoto T., Takenoshita S., Kato M., Miyazono K. Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad. 2(and Smad3. J. Biol. Chem. 274):1999;703-709
42. Ye H., Park Y.C., Kreishman M., Kieff E., Wu H. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell. 4:1999;321-330
43. Zawel L., Dai J.L., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., Kern S.E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell. 1:1998;611-617
44. Zhang Y., Feng X.H., Wu R.Y., Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature. 383:1996;168-172